The Journal of Infectious Diseases · 2007 · 70 citations · 11 references
Hepatitis C VirusImmunologyPathologyViral PersistenceViral HepatitisAccelerated CourseSerum LevelsPrimary ImmunodeficiencyAutoimmune DiseaseLiver PhysiologyVirologyAutoimmunityChronic Viral InfectionHivPatients CoinfectedHepatologyHepatitis CAntiviral ResponseHepatitisAntiviral TherapyLiver DiseaseMedicineViral Immunity
Coinfection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) is associated with an accelerated course of HCV infection and a faster progression to severe liver disease. We have investigated whether the development of liver disease in coinfected patients is associated with specific chemokine and cytokine production. Four cohorts--HCV/HIV-coinfected patients, HCV-monoinfected patients, HIV-monoinfected patients, and healthy control subjects--were studied. Serum levels of the 10-kDa interferon- gamma -inducible protein (IP-10) were higher in all 3 groups of infected patients than in control subjects (P<.0001). HCV/HIV-coinfected patients had significantly higher IP-10 levels than monoinfected patients. In HCV-monoinfected patients, liver fibrosis scores and liver enzyme levels were positively correlated with IP-10 levels. Elevated IP-10 levels are associated with and may contribute to liver damage in both HCV-monoinfected and HCV/HIV-coinfected patients.
11
Basilio Soto, A Sánchez-Quijano, Juan A. del Olmo et al. · Journal of Hepatology · 1997 · 707 citations
Ana I. Romero, Martin Lagging, Johan Westin et al. · The Journal of Infectious Diseases · 2006 · 213 citations · Full text
Pegylated IFN-α2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients
Mayte Pérez‐Olmeda, Marina Núñez, Míriam Romero et al. · AIDS · 2003 · 200 citations